Scientists comment on new WHO guidelines for GLP-1 medications for the treatment of obesity, published by JAMA. Dr Marie Spreckley, … read more
Scientists respond to article published in Nature Medicine exploring the link between weight-loss drugs and food cravings. Dr Simon Cork, Senior … read more
A study published in the Lancet looks at semaglutide and cardiovascular health regardless of weight loss. Dr Sonya Babu-Narayan, Clinical Director, … read more
An unpublished conference abstract presented at the European Association for the Study of Diabetes (EASD) looks at a new RNA-based weight … read more
A study published in JAMA Pediatrics looks at the safety of weight loss drugs in children and adolescents with obesity or type … read more
Two studies published in The Lancet Diabetes & Endocrinology looks at the effect of higher doses of semaglutide on weight loss … read more
An observational study published in JAMA Oncology looks at GLP-1 receptor agonists and cancer risk in adults with obesity. Prof Paul … read more
Scientists comment on oral GLP-1 (Orforglipron) and weight loss from a phase 3 clinical trial. Dr Simon Cork, Senior … read more
A study published in Cell Metabolism looks at the effects of semaglutide on skeletal muscle mass in mice. Prof Lora Heisler, … read more
An observational study published in BMJ Open Diabetes Research & Care looks at GLP-1 drugs vs metformin and the risk of … read more
A study published in JAMA Network Open looks at the association between people with obesity and diabetes taking weight loss drugs, … read more